Use app for best experience!
Available for Android Device.

Nureca Limited IPO Detail

Nureca Limited IPO Detail

Incorporated in 2016, Nureca Limited is a healthcare and wellness products distributor. The company aims to offer the best quality, durable, and innovative tools to customers to monitor chronic diseases to improve their lifestyle.

The firm has a well-diversified product portfolio including Chronic Device Products, Orthopedic products, Mother and Child products, Nutrition Supplements, and Lifestyle products to meet the Indian healthcare market requirements. It is the first digital company to sell such products through its website and other online partners i.e. e-commerce players, retailers, and distributors.

Competitive strengths

  • Diversified product portfolio.
  • Experienced promoter and management team.
  • Strong online distribution network.
  • Premium quality healthcare and wellness products.

Company Promoters

Saurabh Goyal is the promoter of the company.

IPO Details

IPO Opening DateFeb 15, 2021
IPO Closing DateFeb 17, 2021
Issue TypeBook Built Issue IPO
Face Value₹10 per equity share
IPO Price ₹396 - 400 per equity share
Market Lot35 Shares
Min Order Quantity35 Shares
Listing AtBSE, NSE
Issue Size₹100 Cr
Fresh IssueEq Shares of ₹10 (aggregating up to ₹100.00 Cr)
Offer for Sale-
Retail Portion -

IPO Tentative Timetable

The Nureca Limited IPO open date is Feb 15, 2021, and the close date is Feb 17, 2021. The issue may list on Feb 25, 2021.

IPO Open DateFeb 15, 2021
IPO Close DateFeb 17, 2021
Basis of Allotment DateFeb 23, 2021
Initiation of RefundsFeb 24, 2021
Credit of Shares to Demat AccountFeb 24, 2021
IPO Listing DateFeb 25, 2021

IPO Lot Size

The Nureca Limited IPO market lot size is 35 shares. A retail-individual investor can apply for up to 14 lots (490 shares or ₹196000).

ApplicationLotsSharesAmount (Cut-off)

IPO Promoter Holding

Pre Issue Share Holding93.33%
Post Issue Share Holding70%

Company Financials:

For the year/period ended (₹ in Crs)

Financial Year Total Assets Total Revenue Profit After Tax
30-Sep-20 1,024.88 1,229.73 361.80
31-Mar-20 338.83 994.87 63.95
31-Mar-19 235.18 619.83 62.26
31-Mar-18 70.19 200.69 31.12

Objects of the Issue:

The IPO proceed will be utilized towards following purposes:

  • To meet the working capital requirements of the business.
  • To meet general corporate purposes.